WHO ICTRP trial
Randomized, placebo-controlled, single blind, crossover clinical study to…
JPRN-UMIN000000567 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000000567 |
|---|---|
| Public title | Randomized, placebo-controlled, single blind, crossover clinical study to evaluate the relationship between subjective sedation after a single dose of ebastine and gene polymorphisms in pharmacodynamics and pharmacokinetics of ebastine. The healthy Japanese volunteers had experience with subjective sedation after taking the second generation histamine H1 receptor antagonists. |
| Scientific title | Randomized, placebo-controlled, single blind, crossover clinical study to evaluate the relationship between subjective sedation after a single dose of ebastine and gene polymorphisms in pharmacodynamics and pharmacokinetics of ebastine. The healthy Japanese volunteers had experience with subjective… |
| Primary sponsor | Showa University School of Pharmaceutical Sciences Department of Clinical Pharmacy |
| Secondary sponsors | Showa University School of Medicine Second Department of Pharmacology |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Japanese healthy volunteers who had experience with subjective sedation after taking the second generation of histamine H1 receptor antagonist. |
| Interventions | Ebastine 10mg single oral dose group Matched placebo group |
| Registration date | Jan 3, 2007 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: